Market Overview

Sigma-Aldrich, Merck KGaA, Obtain EC Antitrust Approval on Planned Acquisition


Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has secured final approval from the European Commission (EC) on the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany.

The EC provided conditional approval of the acquisition on June 15, 2015, subject to approval of the divestment of certain Sigma-Aldrich assets.  On October 20, 2015, Sigma-Aldrich announced an agreement to sell parts of its solvents and inorganics business to Honeywell.  The EC has now approved Honeywell as a suitable buyer of the divestment business meaning all closing requirements have been met and the formal completion of the Sigma-Aldrich acquisition will take place on November 18.

On September 22, 2014, Merck and Sigma-Aldrich announced they had entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17 billion - $140 cash per share - establishing one of the leading players in the $130 billion global life science industry.

About Sigma-Aldrich:  Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 250,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With

See full press release


Related Articles (SIAL)

View Comments and Join the Discussion!

Posted-In: M&A News Press Releases

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at